NNVC - NanoViricides, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc.

NNVC 2.015

+21.4%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: donpat	8/23/2018 4:18:19 PM
	Read Replies (4) of 12871

Amazing spin-off Pioneering Regenerative Cell Therapy Technologies Ready for Spin-offAdditionally, AllExcel scientists have developed a factory-manufacturable cell line to treat Parkinson's disease (PD). PD is caused by the death of substantia nigra cells in the brain. Our approach is to replace these cells with HLA-matched cells, like organ transplant, but factory- manufactured (unlike organ transplant) so that the patient can carry on a normal life. While several researchers are working on cell replacement approaches, their approaches are limited because of use of stem cells from certain sources and the need for retroviral vector engineering of those cells. If successful, such implantation would cure PD. Currently there is no cure for PD, and existing therapies have significant side-effects and also become progressively ineffective. AllExcel is currently seeking investments to spin-off this technology into a separate company, as we have done in the past with TheraCour Pharma, Inc., and NanoViricides, Inc.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next